Business Wire

IDEMIA

14.12.2020 10:32:12 CET | Business Wire | Press release

Share
IDEMIA Selected by the Icelandic Police for Their New Entry/Exit System

IDEMIA:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005279/en/

Security and convenience at the heart of the Icelandic project

By 2022, new EU-EES regulations will require that biometric data, including face and fingerprints, of Third Country Nationals (TCNs) be captured and identified at the Schengen Area’s external borders. This will affect border check processes for all Schengen Member States.

With 20%-a-year air traffic growth (prior to COVID-19), Iceland planned to implement a program to manage increased passenger flows primarily in Iceland’s main international airport Keflavik, where 95% of the country’s largely non EU arriving and exiting passengers pass, and also in the country’s 30 seaports defined as external sea border crossing points. The new border management systems and equipment will also contribute to inland control within the Schengen Area.

Iceland, innovation partner in border management

IDEMIA will leverage its best-in-class biometric and border control expertise to uphold and upgrade Iceland’s border security. Meanwhile, this cutting-edge technology will contribute to more secured external borders and optimize the passenger flow by the use of the newest technology in border management.

This new border management system, based on IDEMIA’s Augmented Borders™ solution, will be compliant with EU-EES regulations. IDEMIA will also equip Icelandic border crossing points with its TravelKiosk™ EU-EES, the latest generation of user-centric multi-biometric border self-service kiosks . Also including automated TraveLane™ eGates, the entire system will boost throughput and convenience of passengers as they go through border controls. Lastly, to complete this end-to-end solution, IDEMIA will ensure that operator-manned counters, mobile solutions and tracking systems are set up to fit the requirements of the Icelandic Police with a view to shortening response times and improving coordination.

“The National Commissioner of the Icelandic Police, the Metropolitan Police and Sudurnes District police have from early 2019 been working on the implementation of EES in Iceland in close cooperation with Isavia. The procurement procedure started in September 2019 and today we have reached an important milestone by selecting IDEMIA as the supplier and future partner for the implementation of EES in Iceland. The police and Isavia place a high expectation to the collaboration with IDEMIA in the development of solutions that will improve border security and the traveler experience,” said Jón Pétur Jónsson , Chief Superintendent, at the National Commissioner of the Icelandic Police.

Isavia is truly excited about this co-operation with IDEMIA and the Icelandic Police. This is an important step in improving the performance and customer experience of the convenient and easy hub connection between Europe and North America, says Guðmundur Daði Rúnarsson , Chief Commercial and Airport Development Officer at Isavia. The Entry Exit system will affect all airports with traffic crossing external borders. Isavia is confident that implementing IDEMIA’s self service solutions in co-operation with the border police, will result in a more secure and efficient border crossing point, giving Keflavik the potential to grow even further in its Hub operation.

“IDEMIA is proud to accompany Iceland as one of the first countries of the Schengen Area to transform its border control system to comply with the European Entry/Exit System. We are determined to provide a comprehensive set of multi-biometric solutions that will give the assurance of a future-proof program, making Iceland our innovation partner in the implementation of the EU-EES. Our advanced border management solutions, based on a 40-year relationship with governments, will offer a better user experience by interactively adapting the border process per traveler category, while ensuring maximum security,” said Philippe Barreau , Executive Vice President for Public Security & Identity activities at IDEMIA.

As world leader in government identity and police biometric systems, IDEMIA brings to the table its cutting-edge technology and know-how so that personal identity is checked in the most secure way.

Recently, IDEMIA, in partnership with Sopra Steria, was selected to roll out the shared Biometric Matching System - the new European automated multi-biometric identification system for foreign nationals hosted by EU agency eu-LISA. Having partnered with EU institutions for many years and installed border control systems in more than 23 countries, IDEMIA’s comprehensive package meets the complex requirements of border control authorities, topped off by state-of-the-art technology.

About IDEMIA

IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.

Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors. With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit www.idemia.com or follow @IDEMIAGroup on Twitter

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brightfin Unveils AI-Native Platform for IT Financial Management30.4.2026 17:00:00 CEST | Press release

Brightfin clients drive their businesses forward with the first AI Native Cost Optimization Platform Brightfin, the only ITFM and Technology Expense Management solution built natively on ServiceNow, today announced an AI-Native architecture that fundamentally improves how organizations manage IT spend. Rather than bolting AI onto legacy systems, Brightfin has engineered intelligence from the ground up - starting with the data, building contextual awareness on top of it, and delivering AI agents that speak the language of IT finance. Brightfin’s unified budget-to-billing data model creates a stable, governed foundation that connects contracts, invoices, inventory, and budgets into a single source of truth - something no external ITFM tool or native platform module can replicate. This is a structured financial backbone purpose-built for enterprise IT spend, and it’s what makes everything above it possible. A context-aware, AI-Native, intelligence layer understands relationships across th

SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 15:22:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et

Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 15:00:00 CEST | Press release

First-of-its-kind human-to-agent binding service for secure AI-driven commerce, developed with a growing ecosystem of agentic commerce collaborators, including Visa, Cloudflare and Skyfire Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Kn

Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 15:00:00 CEST | Press release

New always-on conversational agent with team race intelligence, team insights, and interactive experiences powered by Infobip AgentOS Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant informat

Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 14:05:00 CEST | Press release

Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burdenEnpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous manifestations, with the goal of broadening the treatment paradigm beyond the current standardsELOWEN is a global Phase 3 program evaluating enpatoran’s impact on both skin and systemic symptoms in patients with lupus and potential links between skin and systemic disease activity Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye